Jon McDunn, PhD, is president of Project Data Sphere, an independent initiative of the CEO Roundtable on Cancer focused on fighting cancer through open-access data sharing and oncology-focused research program initiatives. Previously he was Executive Director of the External Control Arm (ECA) Program and Business Development. The ECA program is a collaborative effort of clinicians, trialists, biostatisticians, and data scientists to use existing clinical data to accelerate and strengthen evidence generation in clinical development. Jon is also the scientific and technical lead for strategic alliances and business development. In this capacity, he scouts and evaluates collaborative opportunities with new and existing partners.

Before joining PDS in 2020, Jon built a startup company, Clinical Sensors. There he secured $4M in NIH SBIR funding, drove the R&D program, and orchestrated its acquisition. Prior to Clinical Sensors, Jon launched two products for Metabolon, “clinical (GSP) biomarkers as a service” and a multianalyte assay for prostate cancer risk assessment. At the beginning of his career, Jon worked in product development at Incyte Genomics.

Jon as held faculty positions at UNC-Chapel Hill (Biomedical Engineering) and Washington University in St. Louis (Anesthesiology). Jon was a postdoctoral fellow in surgical critical care at Washington University in St. Louis; and received in PhD in inflammation biology from The Scripps Research Institute and BS in chemistry from the California Institute of Technology. He has published over 50 peer-reviewed manuscripts and was part of the team that developed the foundational IP for Accuronix.